[DPHARMA] YoY Annualized Quarter Result on 30-Jun-2014 [#2]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
26-Aug-2014
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2014
Quarter
30-Jun-2014 [#2]
Profit Trend
QoQ- -5.01%
YoY- -8.6%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Revenue 480,710 317,210 203,814 162,236 151,652 140,824 136,658 23.29%
PBT 49,528 35,328 41,210 42,604 43,926 35,812 34,332 6.29%
Tax -11,118 -11,790 -11,576 -10,820 -9,150 -8,662 -8,620 4.32%
NP 38,410 23,538 29,634 31,784 34,776 27,150 25,712 6.91%
-
NP to SH 38,434 24,692 29,634 31,784 34,776 27,150 25,712 6.92%
-
Tax Rate 22.45% 33.37% 28.09% 25.40% 20.83% 24.19% 25.11% -
Total Cost 442,300 293,672 174,180 130,452 116,876 113,674 110,946 25.89%
-
Net Worth 463,071 446,334 190,284 179,045 187,340 162,400 154,105 20.10%
Dividend
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Div 13,947 13,947 11,193 11,103 11,101 9,716 9,718 6.20%
Div Payout % 36.29% 56.49% 37.77% 34.93% 31.92% 35.79% 37.80% -
Equity
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Net Worth 463,071 446,334 190,284 179,045 187,340 162,400 154,105 20.10%
NOSH 278,959 278,959 139,915 138,794 138,770 138,803 138,833 12.32%
Ratio Analysis
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
NP Margin 7.99% 7.42% 14.54% 19.59% 22.93% 19.28% 18.81% -
ROE 8.30% 5.53% 15.57% 17.75% 18.56% 16.72% 16.68% -
Per Share
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 172.32 113.71 145.67 116.89 109.28 101.46 98.43 9.77%
EPS 13.76 8.44 21.18 22.90 25.06 19.56 18.52 -4.82%
DPS 5.00 5.00 8.00 8.00 8.00 7.00 7.00 -5.44%
NAPS 1.66 1.60 1.36 1.29 1.35 1.17 1.11 6.93%
Adjusted Per Share Value based on latest NOSH - 138,872
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
RPS 49.97 32.98 21.19 16.87 15.77 14.64 14.21 23.29%
EPS 4.00 2.57 3.08 3.30 3.62 2.82 2.67 6.96%
DPS 1.45 1.45 1.16 1.15 1.15 1.01 1.01 6.20%
NAPS 0.4814 0.464 0.1978 0.1861 0.1948 0.1688 0.1602 20.10%
Price Multiplier on Financial Quarter End Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 30/06/17 30/06/16 30/06/15 30/06/14 28/06/13 29/06/12 30/06/11 -
Price 2.25 2.04 2.65 2.97 2.38 2.23 2.34 -
P/RPS 1.31 1.79 1.82 2.54 2.18 2.20 2.38 -9.46%
P/EPS 16.33 23.05 12.51 12.97 9.50 11.40 12.63 4.37%
EY 6.12 4.34 7.99 7.71 10.53 8.77 7.91 -4.18%
DY 2.22 2.45 3.02 2.69 3.36 3.14 2.99 -4.83%
P/NAPS 1.36 1.28 1.95 2.30 1.76 1.91 2.11 -7.05%
Price Multiplier on Announcement Date
30/06/17 30/06/16 30/06/15 30/06/14 30/06/13 30/06/12 30/06/11 CAGR
Date 25/08/17 22/08/16 25/08/15 26/08/14 28/08/13 16/08/12 18/08/11 -
Price 2.03 2.14 2.40 3.37 2.44 2.38 2.22 -
P/RPS 1.18 1.88 1.65 2.88 2.23 2.35 2.26 -10.25%
P/EPS 14.73 24.18 11.33 14.72 9.74 12.17 11.99 3.48%
EY 6.79 4.14 8.83 6.80 10.27 8.22 8.34 -3.36%
DY 2.46 2.34 3.33 2.37 3.28 2.94 3.15 -4.03%
P/NAPS 1.22 1.34 1.76 2.61 1.81 2.03 2.00 -7.90%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment